EMAIL THIS PAGE TO A FRIEND

Scientific reports

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.


PMID 26586297

Abstract

Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington's disease (HD). Inhibiting mHtt aggregation reduces cell death in the brain and is thus a promising therapeutic approach. The results of the present study demonstrated that mHtt aggregation in the nucleus was altered by the activity of multidrug resistance protein 1 (MDR1), which was experimentally modulated by verapamil, siRNA and an expression vector. MDR1 detoxifies drugs and metabolites through its excretory functions in the membrane compartment, thereby protecting cells against death or senescence. When they were treated with verapamil, R6/2 mice showed a progressive decline in rotarod performance and increased mHtt aggregation in the brain. Using neuronal stem cells from R6/2 mice, we developed an in vitro HD model to test mHtt accumulation in the nuclei of neurons. When MDR1 activity in cells was decreased by verapamil or siRNA, mHtt aggregation in the nuclei increased, whereas the induction of MDR1 resulted in a decrease in mHtt aggregation. Thus, our data provide evidence that MDR1 plays an important role in the clearance of mHtt aggregation and may thus be a potential target for improving the survival of neurons in Huntington's disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

320684
3,3′-Diethyloxacarbocyanine iodide, 98%
C21H21IN2O2
74875
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
C24H21Na3O11S3
D8284
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
C20H10N2Na2O4 · xH2O
D2650
Dimethyl sulfoxide, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
C2H6OS
D8418
Dimethyl sulfoxide, for molecular biology
C2H6OS
D4540
Dimethyl sulfoxide, ≥99.5% (GC), plant cell culture tested
C2H6OS
D1435
Dimethyl sulfoxide, meets EP testing specifications, meets USP testing specifications
C2H6OS
D9170
Dimethyl sulfoxide, PCR Reagent
C2H6OS
D2438
Dimethyl sulfoxide, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
C2H6OS
276855
Dimethyl sulfoxide, anhydrous, ≥99.9%
C2H6OS
41639
Dimethyl sulfoxide, BioUltra, for molecular biology, ≥99.5% (GC)
C2H6OS
673439 Dimethyl sulfoxide solution, 50 wt. % in H2O
C2H6OS
EDS
Ethylenediaminetetraacetic acid, anhydrous, BioUltra, ≥99% (titration)
C10H16N2O8
E6758
Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture
C10H16N2O8
431788
Ethylenediaminetetraacetic acid, 99.995% trace metals basis
C10H16N2O8
E9884
Ethylenediaminetetraacetic acid, ACS reagent, 99.4-100.6%, powder
C10H16N2O8
ED
Ethylenediaminetetraacetic acid, purified grade, ≥98.5%, powder
C10H16N2O8
E8008
Ethylenediaminetetraacetic acid solution, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
C10H16N2O8
316989
Hydrogen peroxide solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis
H2O2
H1009
Hydrogen peroxide solution, 30 % (w/w) in H2O, contains stabilizer
H2O2
18304
Hydrogen peroxide solution, 34.5-36.5%
H2O2
EHU131661 MISSION® esiRNA, esiRNA human ABCB1 (esiRNA1)
EHU026851 MISSION® esiRNA, esiRNA human TBC1D9 (esiRNA1)
P4170
Propidium iodide, ≥94.0% (HPLC)
C27H34I2N4
P4864
Propidium iodide solution, solution (1.0 mg/ml in water)
C27H34I2N4
74255
Sodium dodecyl sulfate, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
C12H25NaO4S
L3771
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
C12H25NaO4S
L6026
Sodium dodecyl sulfate, BioXtra, ≥99.0% (GC)
C12H25NaO4S
436143
Sodium dodecyl sulfate, ACS reagent, ≥99.0%
C12H25NaO4S
L4509
Sodium dodecyl sulfate, ReagentPlus®, ≥98.5% (GC)
C12H25NaO4S